0000000000914919
AUTHOR
Helen Thomas
showing 3 related works from this author
Bioindication of volcanic mercury (Hg) deposition around Mt. Etna (Sicily)
2012
Mt. Etna is a major natural source of Hg to the Mediterranean region. Total mercury concentrations, [Hg] tot, in Castanea sativa (sweet chestnut) leaves sampled 7-13km from Etna's vents (during six campaigns in 2005-2011) were determined using atomic absorption spectroscopy. [Hg] tot in C. sativa was greatest on Etna's SE flank reflecting Hg deposition from the typically overhead volcanic plume. [Hg] tot also showed Hg accumulation over the growing season, increasing with leaf age and recent eruptive activity. [Hg] tot in C. sativa was not controlled by [Hg] tot in soils, which instead was greatest on Etna's NW flank, and was correlated with the proportion of organic matter in the soil (% O…
Ground-Based measurements of the 2014-2015 holuhraun volcanic cloud (Iceland)
2018
he 2014–2015 Bárðarbunga fissure eruption at Holuhraun in central Iceland was distinguished by the high emission of gases, in total 9.6 Mt SO2, with almost no tephra. This work collates all ground-based measurements of this extraordinary eruption cloud made under particularly challenging conditions: remote location, optically dense cloud with high SO2 column amounts, low UV intensity, frequent clouds and precipitation, an extensive and hot lava field, developing ramparts, and high-latitude winter conditions. Semi-continuous measurements of SO2 flux with three scanning DOAS instruments were augmented by car traverses along the ring-road and along the lava. The ratios of other gases/SO2 were …
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCO…
2022
BACKGROUND Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0-14 years) and adults (aged 15-99 years) diagnosed with a haematological malignancy during 2000-14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0-24 years). METHODS We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0-14 years), adolescents (15-19 years), and young adults (20-24 years). We categorised leukaemia subtypes a…